beta-n-methylamino-l-alanine has been researched along with Parkinsonian Disorders in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 10 (55.56) | 29.6817 |
2010's | 7 (38.89) | 24.3611 |
2020's | 1 (5.56) | 2.80 |
Authors | Studies |
---|---|
Brooks, J; Burton, B; Collins, K; Marx, K; Moore, E; Osowski, K; Pawlus, M; Renner, A; Riley, J; Rowe, J; Wilcox, K | 1 |
Banack, SA; Cox, PA | 1 |
Cox, PA; Guillemin, GJ; Kostrzewa, RM | 1 |
Chernoff, N; Diggs, DL; Faison, BD; Francis, BM; Hill, DJ; Lang, JR; Larue, MM; Le, TT; Loftin, KA; Lugo, JN; Schmid, JE; Winnik, WM | 1 |
Banack, SA; Cox, PA; Kokubo, Y; Kuzuhara, S; Metcalf, JS; Morimoto, S; Murayama, S; Togashi, T | 1 |
Nunn, PB | 1 |
Cai, HY; Han, S; Jiang, H; Tian, KW; Zhang, YY | 1 |
Cui, AM; Davenport, B; Garruto, RM; Go, RC; Heizer, JW; Hermosura, MC; Mocz, G; Perraud, AL; Schmitz, C; Shetler, CM | 1 |
Banack, SA; Bradley, WG; Cox, PA | 1 |
Cruz-Aguado, R; Shaw, CA | 1 |
Kisby, G; Palmer, V; Spencer, PS | 1 |
Banack, SA; Bradley, WG; Cheng, R; Nunn, PB | 1 |
Banack, SA; Cox, PA; Murch, SJ; Sacks, OW; Steele, JC | 1 |
Galasko, D; Li, K; Montine, TJ; Perl, DP | 1 |
Miller, G | 1 |
Banack, S; Cox, PA; Murch, S; Sacks, O | 1 |
Papapetropoulos, S | 1 |
Kuzuhara, S | 1 |
4 review(s) available for beta-n-methylamino-l-alanine and Parkinsonian Disorders
Article | Year |
---|---|
BMAA and Neurodegenerative Illness.
Topics: Amino Acids, Diamino; Amyotrophic Lateral Sclerosis; Animals; Cyanobacteria Toxins; Excitatory Amino Acid Agonists; Humans; Parkinsonian Disorders | 2018 |
A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.
Topics: Alzheimer Disease; Amino Acids, Diamino; Amyotrophic Lateral Sclerosis; Animals; Cyanobacteria; Cyanobacteria Toxins; Cycas; Flour; Humans; Neurodegenerative Diseases; Neurotoxins; Parkinsonian Disorders | 2017 |
Is there a role for naturally occurring cyanobacterial toxins in neurodegeneration? The beta-N-methylamino-L-alanine (BMAA) paradigm.
Topics: Amino Acids, Diamino; Cyanobacteria Toxins; Diet; Guam; Humans; Motor Neuron Disease; Nerve Degeneration; Neurodegenerative Diseases; Neurotoxins; Parkinsonian Disorders | 2007 |
[Revisit to Kii ALS--the innovated concept of ALS-Parkinsonism-dementia complex, clinicopathological features, epidemiology and etiology].
Topics: Amino Acids, Diamino; Amyotrophic Lateral Sclerosis; Brain; Cyanobacteria Toxins; Dementia; DNA-Binding Proteins; Humans; Japan; Minerals; Morbidity; Mutation; Parkinsonian Disorders; Superoxide Dismutase; Superoxide Dismutase-1; tau Proteins | 2007 |
14 other study(ies) available for beta-n-methylamino-l-alanine and Parkinsonian Disorders
Article | Year |
---|---|
The biotoxin BMAA promotes dysfunction via distinct mechanisms in neuroblastoma and glioblastoma cells.
Topics: Amino Acids, Diamino; Amyotrophic Lateral Sclerosis; Animals; Cyanobacteria Toxins; Glioblastoma; Humans; Neuroblastoma; Neurotoxins; Parkinsonian Disorders | 2023 |
Creating a Simian Model of Guam ALS/PDC Which Reflects Chamorro Lifetime BMAA Exposures.
Topics: Amino Acids, Diamino; Amyotrophic Lateral Sclerosis; Animals; Brain; Chlorocebus aethiops; Cyanobacteria Toxins; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Guam; Humans; Male; Neurofibrillary Tangles; Parkinsonian Disorders; Plaque, Amyloid | 2018 |
β-N-methylamino-l-alanine analysis in the brains of patients with Kii ALS/PDC.
Topics: Aged; Amino Acids, Diamino; Amyotrophic Lateral Sclerosis; Brain; Chromatography, High Pressure Liquid; Cyanobacteria Toxins; Dementia; Female; Humans; Japan; Male; Mass Spectrometry; Middle Aged; Parkinsonian Disorders | 2017 |
50 years of research on α-amino-β-methylaminopropionic acid (β-methylaminoalanine).
Topics: Amino Acids, Diamino; Amyotrophic Lateral Sclerosis; Animals; Cyanobacteria Toxins; Cycas; Dementia; Guam; Humans; Molecular Structure; Parkinsonian Disorders; Seeds | 2017 |
Angiopoietin-1 and ανβ3 integrin peptide promote the therapeutic effects of L-serine in an amyotrophic lateral sclerosis/Parkinsonism dementia complex model.
Topics: Amino Acids, Diamino; Amyotrophic Lateral Sclerosis; Angiopoietin-1; Animals; Cyanobacteria Toxins; Gene Expression Regulation; Integrin alpha Chains; Male; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley | 2018 |
Altered functional properties of a TRPM2 variant in Guamanian ALS and PD.
Topics: Adenosine Diphosphate Ribose; Amino Acid Sequence; Amino Acids, Diamino; Amyotrophic Lateral Sclerosis; Calcium; Calcium Signaling; Cell Membrane; Conserved Sequence; Cyanobacteria Toxins; Evolution, Molecular; Guam; Humans; Hydrogen Peroxide; Ion Channel Gating; Leucine; Magnesium; Models, Molecular; Molecular Sequence Data; Mutant Proteins; Mutation; Oxidative Stress; Parkinsonian Disorders; Proline; Temperature; TRPM Cation Channels | 2008 |
The ALS/PDC syndrome of Guam and the cycad hypothesis.
Topics: Amino Acids; Amino Acids, Diamino; Amyotrophic Lateral Sclerosis; Bacterial Toxins; Brain; Causality; Cyanobacteria Toxins; Cycas; Dementia; Flour; Guam; Hazardous Substances; Humans; Marine Toxins; Microcystins; Parkinsonian Disorders; Plant Extracts; Syndrome | 2009 |
The ALS/PDC syndrome of Guam and the cycad hypothesis.
Topics: Amino Acids, Diamino; Amyotrophic Lateral Sclerosis; Bacterial Toxins; Causality; Cyanobacteria Toxins; Cycas; Data Interpretation, Statistical; Dementia; Epidemiologic Research Design; Epidemiologic Studies; Flour; Guam; Hazardous Substances; Humans; Incidence; Marine Toxins; Microcystins; Parkinsonian Disorders; Plant Extracts; Sex Distribution; Syndrome | 2009 |
The ALS/PDC syndrome of Guam and the cycad hypothesis.
Topics: alpha-Synuclein; Amino Acids, Diamino; Amyotrophic Lateral Sclerosis; Animals; Bacterial Toxins; Causality; Cyanobacteria Toxins; Cycas; Dementia; Disease Models, Animal; Epidemiologic Research Design; Epidemiologic Studies; Flour; Guam; Hazardous Substances; Humans; Incidence; Indonesia; Japan; Marine Toxins; Methylazoxymethanol Acetate; Microcystins; Nerve Degeneration; Parkinsonian Disorders; Plant Extracts; Syndrome; Tauopathies | 2009 |
Washed cycad flour contains β-N-methyl amino-L-alanine and may explain parkinsonism symptoms.
Topics: Amino Acids, Diamino; Animals; Cyanobacteria Toxins; Cycas; Flour; Neurotoxins; Parkinsonian Disorders; Plant Extracts; Rats | 2011 |
Occurrence of beta-methylamino-l-alanine (BMAA) in ALS/PDC patients from Guam.
Topics: Adult; Aged; Aged, 80 and over; Amino Acids, Diamino; Amyotrophic Lateral Sclerosis; Bacterial Toxins; Case-Control Studies; Cyanobacteria Toxins; Dementia; Female; Frontal Lobe; Guam; Humans; Male; Marine Toxins; Microcystins; Middle Aged; Neurotoxins; Parkinsonian Disorders | 2004 |
Lack of beta-methylamino-l-alanine in brain from controls, AD, or Chamorros with PDC.
Topics: Aged; Alzheimer Disease; Amino Acids, Diamino; Amyotrophic Lateral Sclerosis; Brain; Brain Chemistry; Canada; Cyanobacteria Toxins; Environmental Exposure; Female; Guam; Humans; Male; Middle Aged; Parkinsonian Disorders; Reproducibility of Results | 2005 |
Neurodegenerative disease. Guam's deadly stalker: on the loose worldwide?
Topics: Amino Acids, Diamino; Amyotrophic Lateral Sclerosis; Animals; Brain Chemistry; Chiroptera; Cyanobacteria; Cyanobacteria Toxins; Cycadopsida; Diet; Ethnicity; Food Chain; Guam; Humans; Models, Animal; Neurodegenerative Diseases; Neurotoxins; Parkinsonian Disorders; Seeds; Water Supply | 2006 |
Commentary on: Return of the cycad hypothesis--does the amyotrophic lateral sclerosis/Parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health?
Topics: Amino Acids, Diamino; Amyotrophic Lateral Sclerosis; Bacterial Toxins; Cyanobacteria; Cyanobacteria Toxins; Cycas; Diet; Excitatory Amino Acid Agonists; Guam; Humans; Marine Toxins; Microcystins; Parkinsonian Disorders | 2006 |